\-\ Texto\\:\\ \ \(0\)\
\-\ labs\\ and\\ visual\\ field\\ testing\\:\\ pending\ \(0\)\
\-\ surgical\\ resection\\.\ \(23\)\
\-\ radiological\\ findings\\:\\ \ \(0\)\
\-\ large\\ sellar\\ mass\\ with\\ suprasellar\\ extension\\.\ \(0\)\
\-\ isointense\\ on\\ t1\\,\\ hyperintense\\ t2\\,\\ enhances\\ intensely\\ and\\ heterogeneously\ \(0\)\
\-\ intrasellar\\ expansion\\ \\(ballooning\\ of\\ sella\\)\ \(0\)\
\-\ cavernous\\ sinus\\ involvement\\,\\ no\\ ica\\ involvement\ \(0\)\
\-\ pituitary\\ macroadenoma\ \(8\)\
\-\ 1\\.\\ \\ pituitary\\ macroadenoma\ \(0\)\
\-\ 2\\.\\ \\ craniopharyngioma\\ \\(ca2\\+\\,\\ mural\\ nodule\\,\\ fluid\\/fluid\\ level\\,\\ cystic\\ regions\\)\ \(0\)\
\-\ 3\\.\\ \\ rathke\\'s\\ cleft\\ cyst\\ \\(no\\ enhancement\\)\ \(0\)\
\-\ 4\\.\\ \\ meningioma\\ \\(should\\ be\\ able\\ to\\ define\\ pituitary\\)\ \(0\)\
\-\ 50\\ y\\/o\\ male\\ with\\ decreased\\ libido\\.\ \(1\)\
\-\ no\\ discrete\\ pituitary\\ gland\\ is\\ identified\\ making\\ a\\ pituitary\\ based\\ lesion\\ very\\ likely\\.\\ \\ the\\ size\\ being\\ \\>1cm\\ makes\\ this\\ a\\ macroadenoma\\.\\ \\ mass\\ effect\\ usually\\ make\\ these\\ lesions\\ symptomatic\\.\\ \\ these\\ include\\ hypopituitarism\\,\\ visual\\ symptoms\\ from\\ optic\\ chiasm\\ displacement\\ \\(bitemporal\\ hemianopsia\\ is\\ classic\\)\\,\\ other\\ cranial\\ nerve\\ palsy\\ \\(cavernous\\ location\\ of\\ cns\\ iii\\,\\ iv\\,\\ v\\-1\\,\\ vi\\)\\.\\ \\ macroadenomas\\ can\\ secrete\\ hormonal\\ subunits\\ but\\ are\\ uncommonly\\ functional\\ \\(unlike\\ microadenomas\\)\\.\ \(0\)\
\-\ \\*calcification\\ in\\ macroadenomas\\ is\\ uncommon\\ \\(common\\ in\\ craniopharyngioma\\)\\.\\ cystic\\ regions\\,\\ \\+\\/\\-\\ fluid\\/fluid\\ levels\\,\\ mural\\ nodule\\ also\\ seen\\ in\\ craniopharyngioma\\.\ \(0\)\
\-\ \\*should\\ be\\ able\\ to\\ define\\ pituitary\\ gland\\ in\\ intrasellar\\ extension\\ of\\ meningioma\\.\ \(0\)\
\-\ \\*rathke\\'s\\ cleft\\ cyst\\-doesn\\'t\\ enhance\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pituitary\\:\\ 0\\.3987790234713745\ \(0\)\
\-\ macroadenoma\\:\\ 0\\.2499778503494127\ \(0\)\
\-\ macroadenomas\\:\\ 0\\.2202152081046302\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.2088558441318943\ \(0\)\
\-\ intrasellar\\:\\ 0\\.18979975979539498\ \(0\)\
\-\ define\\:\\ 0\\.1676831687630527\ \(0\)\
\-\ rathke\\:\\ 0\\.15744007772930893\ \(0\)\
\-\ mural\\:\\ 0\\.14719698669556514\ \(0\)\
\-\ cleft\\:\\ 0\\.1301585182501938\ \(0\)\
\-\ able\\:\\ 0\\.12640083054424867\ \(0\)\
\-\ cavernous\\:\\ 0\\.12500254484388706\ \(0\)\
\-\ regions\\:\\ 0\\.12367761204227926\ \(0\)\
\-\ visual\\:\\ 0\\.12295058141042439\ \(0\)\
\-\ gland\\:\\ 0\\.11706380468467549\ \(0\)\
\-\ subunits\\:\\ 0\\.11522914956918698\ \(0\)\
\-\ nodule\\:\\ 0\\.11374373626290692\ \(0\)\
\-\ meningioma\\:\\ 0\\.1079824158337182\ \(0\)\
\-\ ballooning\\:\\ 0\\.10647380967892406\ \(0\)\
\-\ libido\\:\\ 0\\.10647380967892406\ \(0\)\
\-\ involvement\\:\\ 0\\.10430136087540959\ \(0\)\
\-\ microadenomas\\:\\ 0\\.1036552197879604\ \(0\)\
\-\ extension\\:\\ 0\\.10201062757217086\ \(0\)\
\-\ hypopituitarism\\:\\ 0\\.10135226416205217\ \(0\)\
\-\ secrete\\:\\ 0\\.10135226416205217\ \(0\)\
\-\ uncommonly\\:\\ 0\\.09489987989769749\ \(0\)\
\-\ should\\:\\ 0\\.09402974067897037\ \(0\)\
\-\ sellar\\:\\ 0\\.0897783343808256\ \(0\)\
\-\ hormonal\\:\\ 0\\.08896312989839823\ \(0\)\
\-\ bitemporal\\:\\ 0\\.0881973629954834\ \(0\)\
\-\ cystic\\:\\ 0\\.08679068109488375\ \(0\)\
\-\ intensely\\:\\ 0\\.08614454000743457\ \(0\)\
\-\ hemianopsia\\:\\ 0\\.08437916701950819\ \(0\)\
\-\ cyst\\:\\ 0\\.08312995468074297\ \(0\)\
\-\ vi\\:\\ 0\\.08235383323804549\ \(0\)\
\-\ these\\:\\ 0\\.08137714146702482\ \(0\)\
\-\ unlike\\:\\ 0\\.08020779000813531\ \(0\)\
\-\ 1cm\\:\\ 0\\.0764756971974789\ \(0\)\
\-\ chiasm\\:\\ 0\\.0764756971974789\ \(0\)\
\-\ ica\\:\\ 0\\.075352176112347\ \(0\)\
\-\ radiological\\:\\ 0\\.07482579638901614\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.07482579638901614\ \(0\)\
\-\ sella\\:\\ 0\\.07457061022620798\ \(0\)\
\-\ discrete\\:\\ 0\\.07457061022620798\ \(0\)\
\-\ makes\\:\\ 0\\.07226765460029975\ \(0\)\
\-\ making\\:\\ 0\\.07205886826921389\ \(0\)\
\-\ palsy\\:\\ 0\\.07205886826921389\ \(0\)\
\-\ in\\:\\ 0\\.07169823781071817\ \(0\)\
\-\ suprasellar\\:\\ 0\\.07068668321495758\ \(0\)\
\-\ functional\\:\\ 0\\.07068668321495758\ \(0\)\
\-\ no\\:\\ 0\\.07029288432213522\ \(0\)\
\-\ make\\:\\ 0\\.06996469897439155\ \(0\)\
\-\ field\\:\\ 0\\.06772035730721598\ \(0\)\
\-\ cns\\:\\ 0\\.06728724223260066\ \(0\)\
\-\ expansion\\:\\ 0\\.06568958486670652\ \(0\)\
\-\ uncommon\\:\\ 0\\.06519898784560871\ \(0\)\
\-\ testing\\:\\ 0\\.06472673525607829\ \(0\)\
\-\ enhance\\:\\ 0\\.06449706919375954\ \(0\)\
\-\ enhances\\:\\ 0\\.06351231471003685\ \(0\)\
\-\ iii\\:\\ 0\\.06221309371483503\ \(0\)\
\-\ optic\\:\\ 0\\.06202456356655599\ \(0\)\
\-\ pending\\:\\ 0\\.05926223784630946\ \(0\)\
\-\ is\\:\\ 0\\.059196978869113806\ \(0\)\
\-\ cranial\\:\\ 0\\.0588917923687474\ \(0\)\
\-\ displacement\\:\\ 0\\.05874660358125402\ \(0\)\
\-\ be\\:\\ 0\\.05845840669607204\ \(0\)\
\-\ hyperintense\\:\\ 0\\.057315116608490306\ \(0\)\
\-\ levels\\:\\ 0\\.05712324529224018\ \(0\)\
\-\ symptomatic\\:\\ 0\\.05540487506239128\ \(0\)\
\-\ mass\\:\\ 0\\.0550449873705388\ \(0\)\
\-\ classic\\:\\ 0\\.05389252549742467\ \(0\)\
\-\ based\\:\\ 0\\.052193571091618415\ \(0\)\
\-\ sinus\\:\\ 0\\.05206533358975354\ \(0\)\
\-\ very\\:\\ 0\\.05168825229095088\ \(0\)\
\-\ iv\\:\\ 0\\.05148352681360228\ \(0\)\
\-\ calcification\\:\\ 0\\.05144297690577238\ \(0\)\
\-\ nerve\\:\\ 0\\.05140255675786936\ \(0\)\
\-\ identified\\:\\ 0\\.051083769227386604\ \(0\)\
\-\ effect\\:\\ 0\\.05054454712085278\ \(0\)\
\-\ 50\\:\\ 0\\.0503203172306344\ \(0\)\
\-\ being\\:\\ 0\\.05020967752669016\ \(0\)\
\-\ location\\:\\ 0\\.05017301194088389\ \(0\)\
\-\ labs\\:\\ 0\\.04991929035984338\ \(0\)\
\-\ size\\:\\ 0\\.04878737360445158\ \(0\)\
\-\ resection\\:\\ 0\\.046187197549186966\ \(0\)\
\-\ usually\\:\\ 0\\.045360315195217014\ \(0\)\
\-\ t1\\:\\ 0\\.0448938007084705\ \(0\)\
\-\ decreased\\:\\ 0\\.044631384963031914\ \(0\)\
\-\ level\\:\\ 0\\.043524451914569884\ \(0\)\
\-\ likely\\:\\ 0\\.0430573595693088\ \(0\)\
\-\ include\\:\\ 0\\.04287114560063483\ \(0\)\
\-\ of\\:\\ 0\\.04230162259946733\ \(0\)\
\-\ enhancement\\:\\ 0\\.04147271041848977\ \(0\)\
\-\ t2\\:\\ 0\\.041454337636427245\ \(0\)\
\-\ lesions\\:\\ 0\\.041381112588221566\ \(0\)\
\-\ common\\:\\ 0\\.04086255813232177\ \(0\)\
\-\ symptoms\\:\\ 0\\.03942356519591776\ \(0\)\
\-\ can\\:\\ 0\\.03781136688381608\ \(0\)\
\-\ other\\:\\ 0\\.03741851240100969\ \(0\)\
\-\ to\\:\\ 0\\.03602644097321593\ \(0\)\
\-\ but\\:\\ 0\\.035630542671560066\ \(0\)\
\-\ findings\\:\\ 0\\.03556126670938739\ \(0\)\
\-\ surgical\\:\\ 0\\.03502032615413506\ \(0\)\
\-\ lesion\\:\\ 0\\.034544025886479576\ \(0\)\
\-\ seen\\:\\ 0\\.03392217995575014\ \(0\)\
\-\ also\\:\\ 0\\.033891876977343534\ \(0\)\
\-\ male\\:\\ 0\\.03208096686002741\ \(0\)\
\-\ and\\:\\ 0\\.02977792579925676\ \(0\)\
\-\ from\\:\\ 0\\.02861657483045005\ \(0\)\
\-\ with\\:\\ 0\\.028217931872593725\ \(0\)\
\-\ are\\:\\ 0\\.02734100657691088\ \(0\)\
\-\ this\\:\\ 0\\.024758862338328767\ \(0\)\
\-\ on\\:\\ 0\\.021761378099287274\ \(0\)\
\-\ the\\:\\ 0\\.014377273725814443\ \(0\)\
